Adipose triglyceride lipase (ATGL) catalyzes the rate limiting step in triacylglycerol breakdown in adipocytes but is expressed in most tissues. The enzyme was shown to be lost in many human tumors, and its loss may play a role in early stages of cancer development. Here, we report that loss of ATGL supports a more-aggressive cancer phenotype in a model system in which ATGL was deleted in A549 lung cancer cells by CRISPR/Cas9. We observed that loss of ATGL led to triacylglycerol accumulation in lipid droplets and higher levels of cellular phospholipid and bioactive lipid species (lyso- and ether-phospholipids). Label-free quantitative proteomics revealed elevated expression of the pro-oncogene SRC kinase in ATGL depleted cells, which was also found on mRNA level and confirmed on protein level by Western blot. Consistently, higher expression of phosphorylated (active) SRC (Y416 phospho-SRC) was observed in ATGL-KO cells. Cells depleted of ATGL migrated faster, which was dependent on SRC kinase activity. We propose that loss of ATGL may thus increase cancer aggressiveness by activation of pro-oncogenic signaling via SRC kinase and increased levels of bioactive lipids.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.7b00782DOI Listing

Publication Analysis

Top Keywords

loss atgl
12
src kinase
12
adipose triglyceride
8
triglyceride lipase
8
triacylglycerol accumulation
8
a549 lung
8
atgl
7
cells
5
deletion adipose
4
lipase links
4

Similar Publications

PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis.

J Hepatol

November 2024

Department of Molecular Genetics, University of Texas Southwestern Medical Center (UTSW), Dallas, TX 75390-9046, USA; Howard Hughes Medical Institute, UTSW, Dallas, TX 75390, USA; The Eugene McDermott Center for Human Growth and Development, UTSW, Dallas, TX, 75390, USA. Electronic address:

Background & Aims: PNPLA3(148M) (patatin-like phospholipase domain-containing protein 3) is the most impactful genetic risk factor for steatotic liver disease (SLD). A key unresolved issue is whether PNPLA3(148M) confers a loss- or gain-of-function. Here we test the hypothesis that PNPLA3 causes steatosis by sequestering ABHD5 (α/β hydrolase domain-containing protein 5), the cofactor of ATGL (adipose TG lipase), thus limiting mobilization of hepatic triglyceride (TG).

View Article and Find Full Text PDF
Article Synopsis
  • The study explored how the herbal formula Qing-Luo-Yin (QLY) affects SIRT1, a protein that regulates metabolism and immune responses, in a rat model of arthritis.
  • Treatment with QLY showed a significant reduction in fat in the liver and white adipose tissues of the rats, along with improved joint conditions and altered expression of certain SIRT1-related proteins.
  • The research concluded that inhibiting SIRT1 in adipose tissue helps reduce visfatin production in arthritis, which in turn may lessen inflammation, marking a possible anti-rheumatic mechanism of QLY that operates independently of immune regulation.
View Article and Find Full Text PDF

Blockage of ATGL-mediated breakdown of lipid droplets in microglia alleviates neuroinflammatory and behavioural responses to lipopolysaccharides.

Brain Behav Immun

January 2025

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC H3T 1J4, Canada; Département de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada; Food4BrainHealth France-Canada International Research Network, Bordeaux, France. Electronic address:

Article Synopsis
  • Lipid droplets (LD) are essential for storing triglycerides and play a significant role in regulating inflammation in cells, influenced by adipose triglyceride lipase (ATGL).
  • The study examined the effects of inhibiting ATGL and the genetic loss of ATGL in microglia on inflammatory responses, particularly focusing on cytokine expression and phagocytosis during LPS-induced inflammation.
  • Findings showed that ATGL inhibition led to reduced expression of pro-inflammatory cytokines (like IL-1β and IL-6), decreased inflammation-related behaviors, and altered lipid profiles, signifying ATGL's critical role in modulating neuroinflammatory responses.
View Article and Find Full Text PDF

Lung cancer and cachexia are the leading causes of cancer-related deaths worldwide. Cachexia is manifested by weight loss and white adipose tissue (WAT) atrophy. Limited nutritional supplements are conducive to lung cancer patients, whereas the underlying mechanisms are poorly understood.

View Article and Find Full Text PDF

Interplay of FXN expression and lipolysis in white adipocytes plays a critical role in insulin sensitivity in Friedreich's ataxia mouse model.

Sci Rep

August 2024

Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, 210093, People's Republic of China.

Frataxin (FXN) is required for iron-sulfur cluster biogenesis, and its loss causes the early-onset neurodegenerative disease Friedreich ataxia (FRDA). Loss of FXN is a susceptibility factor in the development of diabetes, a common metabolic complication after myocardial hypertrophy in patients with FRDA. The underlying mechanism of FXN deficient-induced hyperglycemia in FRDA is, however, poorly understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!